scispace - formally typeset
L

Lyle L. Moldawer

Researcher at University of Florida

Publications -  477
Citations -  36763

Lyle L. Moldawer is an academic researcher from University of Florida. The author has contributed to research in topics: Sepsis & Cytokine. The author has an hindex of 93, co-authored 460 publications receiving 33252 citations. Previous affiliations of Lyle L. Moldawer include McKnight Brain Institute & University of Florida Health Science Center.

Papers
More filters
Journal ArticleDOI

Genomic responses in mouse models poorly mimic human inflammatory diseases

TL;DR: This study shows that, although acute inflammatory stresses from different etiologies result in highly similar genomic responses in humans, the responses in corresponding mouse models correlate poorly with the human conditions and also, one another.
Journal ArticleDOI

A network-based analysis of systemic inflammation in humans

TL;DR: This work explores the known genome-wide interaction network to identify significant functional modules perturbed in response to an inflammatory stimulus and reveals that the human blood leukocyte response to acute systemic inflammation includes the transient dysregulation of leukocytes bioenergetics and modulation of translational machinery.
Journal ArticleDOI

A genomic storm in critically injured humans

Wenzhong Xiao, +96 more
TL;DR: It is shown that critical injury in humans induces a genomic storm with simultaneous changes in expression of innate and adaptive immunity genes that alter the status of these genes in the immune system.
Journal ArticleDOI

Sepsis and septic shock

TL;DR: With earlier recognition and more compliance to best practices, sepsis has become less of an immediate life-threatening disorder and more of a long-term chronic critical illness, often associated with prolonged inflammation, immune suppression, organ injury and lean tissue wasting.
Journal ArticleDOI

Tumor necrosis factor soluble receptors circulate during experimental and clinical inflammation and can protect against excessive tumor necrosis factor alpha in vitro and in vivo.

TL;DR: It is reported that two types of naturally occurring soluble TNF receptors circulate in human experimental endotoxemia and in critically ill patients and demonstrate that they neutralize TNF alpha-induced cytotoxicity and immunoreactivity in vitro.